Asensus Surgical, Inc. financial data

Symbol
ASXC on NYSE, TRXDW on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
1 Tw Alexander Drive, Suite 160, Durham, NC
State of incorporation
Delaware
Fiscal year end
December 31
Former names
TRANSENTERIX, INC. (to 2/23/2021), TRANSENTERIX INC. (to 7/10/2019), SafeStitch Medical, Inc. (to 12/10/2013), CELLULAR TECHNICAL SERVICES CO INC (to 2/11/2008)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 144 % -81%
Quick Ratio 32.1 % -61.9%
Debt-to-equity 154 % +728%
Return On Equity -407 % -352%
Return On Assets -160 % -111%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 273M shares +3.4%
Common Stock, Shares, Outstanding 273M shares +13.6%
Entity Public Float 120M USD +29%
Common Stock, Value, Issued 273K USD +13.8%
Weighted Average Number of Shares Outstanding, Basic 272M shares +13.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.85M USD +39%
Research and Development Expense 33.6M USD -2.19%
Selling and Marketing Expense 15.2M USD -7.43%
General and Administrative Expense 18.9M USD -6.46%
Operating Income (Loss) -84.4M USD -5.06%
Nonoperating Income (Expense) 990K USD +9.51%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -83.4M USD -5.01%
Income Tax Expense (Benefit) 356K USD +56.1%
Net Income (Loss) Attributable to Parent -83.8M USD -5.15%
Earnings Per Share, Basic -0.3 USD/shares +11.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.78M USD +1.39%
Accounts Receivable, after Allowance for Credit Loss, Current 406K USD -38.5%
Inventory, Net 7.16M USD -21.2%
Other Assets, Current 1.36M USD -8.58%
Assets, Current 19.4M USD -64.6%
Deferred Income Tax Assets, Net 34K USD -78.1%
Property, Plant and Equipment, Net 8.03M USD -8.86%
Operating Lease, Right-of-Use Asset 4.69M USD -4.09%
Other Assets, Noncurrent 1.26M USD -33.6%
Assets 38.5M USD -50.9%
Accounts Payable, Current 2.06M USD -52%
Employee-related Liabilities, Current 3.98M USD +2.32%
Accrued Liabilities, Current 2.61M USD +103%
Contract with Customer, Liability, Current 496K USD +31.9%
Liabilities, Current 39.9M USD +275%
Contract with Customer, Liability, Noncurrent 258K USD
Operating Lease, Liability, Noncurrent 4.05M USD -12.9%
Liabilities 49.8M USD +195%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.27M USD -1.11%
Retained Earnings (Accumulated Deficit) -988M USD -9.27%
Stockholders' Equity Attributable to Parent -11.3M USD -118%
Liabilities and Equity 38.5M USD -50.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14M USD +18.8%
Net Cash Provided by (Used in) Financing Activities 811K USD
Net Cash Provided by (Used in) Investing Activities 3M USD -89.9%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 273M shares +13.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.3M USD -183%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.3M USD +2.99%
Deferred Tax Assets, Valuation Allowance 111M USD +16.7%
Deferred Tax Assets, Gross 112M USD +16.6%
Operating Lease, Liability 5.12M USD -6.43%
Depreciation 841K USD +3.44%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -83.8M USD -7.97%
Lessee, Operating Lease, Liability, to be Paid 6.37M USD -10.1%
Property, Plant and Equipment, Gross 25M USD +12.7%
Operating Lease, Liability, Current 1.07M USD +30.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.06M USD -10.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.39M USD +10.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.25M USD -22.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.01M USD +2.97%
Deferred Tax Assets, Operating Loss Carryforwards 93.3M USD +11.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 715K USD +113%
Lessee, Operating Lease, Liability, to be Paid, Year Four 825K USD -7.92%
Operating Lease, Payments 351K USD +6.36%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 451K USD -83.5%
Deferred Tax Assets, Net of Valuation Allowance 1.49M USD +7.49%
Share-based Payment Arrangement, Expense 7.3M USD -8.58%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%